Skip to main content.

Dr. Chen’s has published over 200 articles in peer-reviewed journals. His research focuses on the comparative effectiveness of different treatment options in prostate cancer, issues related to cancer survivorship, patient-reported outcomes and quality of life, and cancer disparities. His research has been funded by the National Institutes of Health and National Cancer Institute, Patient-Centered Outcomes Research Institute, Department of Defense, and other funding agencies.

 Dr. Chen leads or co-leads several national and international clinical trials in prostate cancer, bladder cancer, kidney cancer and testicular cancer:

NC ProCESS: North Carolina Prostate cancer Comparative Effectiveness & Survivorship Study

  • In 2010, Dr. Chen’s team started a project that enrolled 1,500 men with newly-diagnosed prostate cancer from across North Carolina for a prospective observational study.
  • Yearly, the study team collects information on patient-reported quality of life, cancer recurrence, mortality, and long-term issues related to cancer survivorship and overall health.

 Multiple high-impact publications have resulted from this project. Some examples include:

Research using insurance claims data: Dr. Chen’s team has expertise in analyzing large datasets including insurance claims data (e.g. SEER-Medicare) to answer research questions related to comparative effectiveness, patterns of care, cancer disparities, and costs of cancer care. Most recently, the research team has used insurance claims data to examine how COVID has impacted cancer care across the US.

 Multiple high-impact publications have resulted from this research. Some examples include:

Dr. Chen welcomes opportunities to support undergraduate students, medical students, postdoctoral researchers, residents, fellows, junior faculty and visiting scholars.

Please contact Dr. Chen at: rchen2@kumc.edu

Recent Publications 

 

 

 

School of Medicine

Radiation Oncology
3901 Rainbow Boulevard
Kansas City, KS 66160
913-588-5000